PHILADELPHIA, Feb. 22, 2017 /PRNewswire/ -- Aberdeen
Israel Fund, Inc. (the "Fund") (NYSE MKT: ISL), a closed-end
equity fund, announced today its performance data and portfolio
composition as of January 31,
2017.
The Fund's total returns for various periods through
January 31, 2017 are provided
below. (All figures are based on distributions reinvested at
the dividend reinvestment price and are stated
net-of-fees):
|
Cumulative as of
01/31/17
|
Annualized as of
01/31/17
|
|
1
Month
|
3
Month
|
YTD
|
1
Year
|
3
Years
|
5
Years
|
10
Years
|
Since
Inception
|
|
NAV
|
2.4
|
3.1
|
2.4
|
3.3
|
3.5
|
8.0
|
6.1
|
7.1
|
|
Market
Price
|
1.7
|
3.9
|
1.7
|
5.6
|
2.1
|
6.8
|
4.7
|
6.3
|
|
TA-100
|
-1.0
|
2.9
|
-1.0
|
2.8
|
-1.1
|
4.0
|
3.9
|
n/a¹
|
On January 31, 2017, the Fund's
net assets amounted to US$77.7
million and the Fund's NAV per share was US$19.59.
As of January 31, 2017, the
portfolio was invested as follows:
|
Portfolio
Composition
|
Percent of
Net Assets
|
|
Information
Technology
|
30.8
|
|
Health
Care
|
15.7
|
|
Financials
|
15.4
|
|
Materials
|
10.6
|
|
Consumer
Staples
|
6.9
|
|
Telecommunications
|
5.3
|
|
Industrials
|
5.0
|
|
Real
Estate
|
4.9
|
|
Consumer
Discretionary
|
3.5
|
|
Cash
|
2.0
|
The Fund's ten largest equity holdings as of January 31, 2017, representing 69.9% of net
assets, were:
|
Stock
|
Percent
of
Net
Assets
|
|
Check Point Software
Technologies
|
14.5
|
|
Frutarom
Industries
|
8.5
|
|
Ituran Location and
Control
|
7.6
|
|
Teva Pharmaceutical
Industries
|
7.1
|
|
Perrigo
|
6.8
|
|
Elbit Systems
Ltd.
|
5.4
|
|
Mizrahi Tefahot
Bank
|
5.2
|
|
Azrieli
Group
|
5.1
|
|
Nice Systems
Ltd.
|
5.0
|
|
Bank
Hapoalim
|
4.8
|
Important Information
Aberdeen Asset Management Inc.
has prepared this report based on information sources believed to
be accurate and reliable. However, the figures are unaudited
and neither the Fund, Aberdeen Asset Managers Limited (the
Investment Adviser), nor any other person guarantees their
accuracy. Investors should seek their own professional advice
and should consider the investment objectives, risks, charges and
expenses before acting on this information. Aberdeen is a U.S.
registered service mark of Aberdeen Asset Management PLC.
Closed-end funds are traded on the secondary market through one
of the stock exchanges. The Fund's investment return and principal
value will fluctuate so that an investor's shares may be worth more
or less than the original cost. Shares of closed-end funds may
trade above (a premium) or below (a discount) the net asset value
(NAV) of the fund's portfolio. There is no assurance that the Fund
will achieve its investment objective.
Total return figures with distributions reinvested at the
dividend reinvestment price are stated net-of-fees and represents
past performance. Past performance is not indicative of
future results, current performance may be higher or lower.
Holdings are subject to change and are provided for informational
purposes only and should not be deemed as a recommendation to buy
or sell the securities shown. Inception date October 29, 1992.
If you wish to receive this information electronically, please
contact: InvestorRelations@aberdeen-asset.com
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/aberdeen-israel-fund-inc-announces-performance-data-and-portfolio-composition-300411849.html
SOURCE Aberdeen Israel Fund, Inc.